CereVasc, Inc. announced it has received its second FDA Breakthrough Device designation for the investigational eShunt system ...

Perfuze, an Ireland-based developer of catheter-based technology for the treatment of acute ischemic stroke, announced the ...

Perfuze, an Ireland-based developer of catheter-based technology for the treatment of acute ischemic stroke, announced the ...

Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced ...

R3 Vascular Inc. announced that the first patient was enrolled in the company’s ELITE-BTK pivotal trial evaluating its Magn ...

Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study demonstrat ...

IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the ...

Aortic dissections are classified by site (Stanford type A, ascending aorta; type B, descending aorta) and chronicity (acute if onset of symptoms 2 weeks, chronic if > 2 weeks). The acute group can ...

In an article published online in Journal of Vascular Surgery evaluating radiation dose exposure for vascular surgery ...

Venova Medical announced the completion of patient enrollment for the company’s VENOS-2 early feasibility study. Accordi ...

Multiple factors, rather than a single process, are implicated in the pathogenesis of TAA. Whereas abdominal aneurysms are characterized by severe intimal atherosclerosis, chronic transmural ...

Venous return is attained through a complex interaction of valves, muscle pumps, and pressure gradients and is greatly influenced by position. In the upright position, gravity is counteracted by the ...